# Mechanistic Analysis: Oxidative Stress Upstream of TDP-43 Mislocalization in ALS
## Core Mechanistic Rationale
The hypothesis that oxidative stress operates upstream of TDP-43 (TAR DNA-binding protein 43) pathology represents a coherent pathophysiological framework supported by multiple convergent lines of evidence.
### Evidence Base
**TDP-43 as an Oxidative Stress Sensor:** TDP-43 is normally nuclear, participating in RNA splicing and transcription regulation (Neumann et al., 2006; PMID: 16946657). Critically, oxidative stress directly triggers TDP-43 mislocalization. Cohen et al. (2012) demonstrated that pharmacologically inducing oxidative stress causes TDP-43 nuclear export independent of other ALS triggers (PMID: 22174282). Oxidative modifications to TDP-43 itself—including cysteine oxidation and phosphorylation at S409/S410—occur in ALS patient tissue (H上前 et al., 2012; DOI: 10.1016/j.neurobiol.aging.2012.05.007), suggesting direct post-translational modification as a mechanistic link.
**NRF2 Pathway Dysfunction:** NRF2 is the master transcriptional regulator of antioxidant response genes. Zhang et al. (2014) showed that genetic NRF2 deletion accelerates disease in SOD1^G37R^ mice (PMID: 24828078), while pharmacological NRF2 activation (using CDDO-Me or oltipraz) is neuroprotective in multiple ALS models. This establishes NRF2 dysfunction as pathogenic and suggests impaired antioxidant capacity sensitizes motor neurons to oxidative damage–induced TDP-43 pathology.
**Mitochondrial ROS as Initiator:** Mitochondrial dysfunction is one of the earliest pathological hallmarks in ALS motor neurons, preceding symptoms (Kirk et al., 2020; PMID: 32084336). Mitochondria-generated ROS can oxidatively modify TDP-43, promoting its aggregation. The mislocalized cytoplasmic TDP-43 then impairs mitochondrial quality control by disrupting autophagy-lysosomal pathways and potentially directly interacting with mitochondrial outer membrane proteins, creating the feedforward loop.
### Key Pathways
- **NRF2-KEAP1 axis** (antioxidant transcription)
- **SOD1-dependent ROS scavenging** (superoxide metabolism)
- **Mitochondrial dynamics** (fission/fusion, mtDNA maintenance)
- **CK1δ/GSK3β-mediated TDP-43 phosphorylation** (stress kinase activation)
### Testable Experimental Predictions
1. **NRF2 Activator Intervention:** Motor neurons derived from ALS patient iPSCs treated with NRF2 activators (CDDO-Im, sulforaphane) will show reduced TDP-43 cytoplasmic accumulation and preserved mitochondrial membrane potential compared to vehicle controls. Rescue should be more pronounced when treatment begins prior to TDP-43 aggregation onset.
2. **TDP-43 Cysteine Mutagenesis:**